Company / Operating Cash Flow
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$11.0M
FY2025
5-year range
-$12.9M / -$3.4M
FY2021-FY2025
Trend
+14.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$13M in FY2024 to -$5,092 in FY2011.
Based on SEC 10-K filings.
-$11M in FY2025.
Declined from -$8M to -$11M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 14.5% year-over-year.
- Peak operating cash flow was recorded in FY2011.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.0M | +14.5% |
| FY2024 | -$12.9M | -71.4% |
| FY2023 | -$7.5M | +12.6% |
| FY2022 | -$8.6M | -151.2% |
| FY2021 | -$3.4M | -11231.2% |
| FY2016 | -$30.2K | -15.5% |
| FY2015 | -$26.2K | -4.3% |
| FY2014 | -$25.1K | +8.5% |
| FY2012 | -$27.4K | -438.6% |
| FY2011 | -$5.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026